SALES MANAGEMENT REPORT
Sohaib Afzal Rana
At first of all we would like to thank Almighty Allah y the blessings of whom we are able to finalize this report. We would also like to acknowledge the efforts of following personnel as their kind coordination and cooperation really enabled us to compile this report.
Tahir Ahmed , GM Sales
Ahmed Bin Qasim – GM Marketing
Athar Iqbal , Group Head Human Resources
We would also like to thank our esteemed instructor Mr. Javed Mehmood who imparts us the core knowledge of Sales Management which is of great help in compiling this report.
Searle is one of the leading pharmaceutical companies in Pakistan having four state-of the-art manufacturing facilities, two in Karachi and two in Lahore, Pakistan.
Searle Pakistan Limited (SPL) was incorporated in Pakistan as a Private Limited Company on October 5, 1965 as a subsidiary of G.D. Searle & Co., U.S.A. In 1966, Searle Pakistan (Private) Limited acquired a small manufacturing facility in S.I.T.E. and production of Aldactone, Lomotil, Diodoquin, Ovulen, Neomycin Sulphate, Probanthine and Hydryllin, etc. started there. Over the years the operation expanded and during 1984 construction of a new factory started. During the year 1986 manufacturing operations of high quality pharmaceutical products were integrated at the newly built factory at Plot # F-319, S.I.T.E. Area, Karachi, measuring 5.24 acres.
On 29th April 1993, G.D. Searle & Company as part of its global policy, disinvested its shares in Pakistan. On November 14, 1993, the company was converted into a Public Limited Company As a further milestone, during 1996 Ministry of Health, Islamabad, also allowed the manufacturing of Antibiotic products in a dedicated area constructed within SPL present manufacturing facility where production of some excellent antibiotic drugs is being carried out. During 1996 SPL also joined a limited group of Pharmaceutical Companies, which are allowed to manufacture semi-basic active raw material for pharmaceutical preparations in their manufacturing facilities.
* Searle's manufacturing facility conforms to the strictest requirements of GMP and employs systems and procedures of the highest standards to provide manufacturing, quality control, warehousing and physical distribution services to the company, medical profession and ultimate users. * The plant is being significantly expanded in all areas to cater for its ever expending manufacturing operations in future.
* SPL is one of the leading pharmaceutical companies in Pakistan having two state-of-the art manufacturing facilities in Karachi and Lahore. The manufacturing plants are the most modern in the country. The company has consistently invested heavily in new technologies and state-of-the-art equipment, which has been instrumental in improving plant efficiencies and curtailing manufacturing costs. * SPL has a fully developed and professional marketing operation divided into four separate business lines. The first line which deals with G.D. Searle, Grunenthal - Germany, Forest Laboratories U.K. Limited, 3M - England, Orion Pharma - Finland, Lisapharma - Italy and SPL's own developed products is headed by Director Marketing, Searle Pharma. * The second line deals with products licensed from Sanofi Aventis, as well as Menarini and SPL's own developed products and is headed by Director Marketing Searle Pharma Division II. * The third line deals with Consumer items and is supervised by Group Brand Manager, Consumer Products. Fourth line deals with export business. International Business Division is headed by Senior Manager International Businesss. * Searle enjoys an excellent reputation in the field of pharmaceuticals and health care products throughout the country and is recognized as a dedicated provider of quality healthcare products committed to research and development...
Please join StudyMode to read the full document